Diabetes drug Avandia gets new setback ahead of US decision
Saturday, July 10, 2010 - 05:42
in Health & Medicine
GlaxoSmithKline's blockbuster diabetes treatment Avandia suffered a new setback Friday when US health officials offered more evidence of the drug's increased link to heart problems.